If you were planning to put new ACA producers on the board for 2027, CMS just changed your timeline. On September 22, 2026, HHS issued an interim final rule (CMS-9872-IFC) that immediately pauses Federally-facilitated Marketplace registration for agents and brokers who did not hold a Plan Year 2026 Exchange agreement. The pause runs through February 1, 2027 — which means it covers the entire 2027 Open Enrollment Period.
Most of the coverage you will read on this rule stops at “new agents can’t register.” That is true, but it is the least useful part of the rule for an agency. The more important material is buried in the regulatory impact analysis, where CMS puts a dollar figure on what this costs the agencies that already did the hiring. We will get to that.
The one-sentence version
Registered for PY2026? You are unaffected. Complete your 2027 training and registration as usual.
Not registered for PY2026? You cannot execute a PY2027 Exchange agreement with the FFM or an SBE-FP state until the moratorium lifts. A resident license, carrier appointments, and finished MLMS coursework will not get you around it — CMS simply will not execute the agreement.
What CMS actually changed in the regulation
HHS added a new paragraph at 45 CFR § 155.220(o). This is the part worth understanding, because it outlives the current pause.
Before this rule, CMS’s tools were individual and reactive. Section 155.220(g) lets it terminate a specific agent’s agreement; 155.220(k)(3) lets it suspend a specific agent’s ability to transact. Both operate after someone is registered and already moving business.
Paragraph (o) is different in kind. It gives HHS standing authority to pause registrations as a class whenever it determines that agent, broker, or web-broker conduct “systemically poses an unacceptable risk” to eligibility accuracy, Exchange operations, applicants, enrollees, or Exchange IT systems. CMS has to publish a Federal Register notice stating the effective date, the reasons, and the duration — but the authority itself is now permanent, and this moratorium is simply its first use.
In other words: the February 1 date is about this pause. The rule that made the pause possible does not expire.
The carve-out nobody is mentioning
There is a narrow exception written into § 155.220(o) that is easy to miss and matters to a specific group of producers.
The moratorium does not block registration for an agent who lacks a current Plan Year registration because of (1) a termination under § 155.220(g), or (2) a denial of the right to enter into future Exchange agreements under § 155.220(k)(1)(i) — where that termination or denial is later reversed, or the agreements are reinstated while the moratorium is in place.
So a producer who was terminated or denied, appealed, and won is not swept up in the pause. If you have an agent in that posture, their path is the reinstatement process, not the registration queue.
State-based Exchanges are not affected — but read the fine print
CMS states plainly that the moratorium “does not affect registrations on the State-based Exchanges (SBEs).” For an agency with a multi-state footprint, this is the single most useful sentence in the rule.
The distinction that trips people up is between a full SBE and an SBE-FP (a State-based Exchange that runs on the federal platform). SBE-FP states use HealthCare.gov’s infrastructure and federal registration — so they are covered by the moratorium. Only full SBEs, which run their own enrollment platforms and their own producer certification, sit outside it.
As of the 2026 plan year there are 21 full SBEs:
California, Colorado, Connecticut, the District of Columbia, Georgia, Idaho, Illinois, Kentucky, Maine, Maryland, Massachusetts, Minnesota, Nevada, New Jersey, New Mexico, New York, Pennsylvania, Rhode Island, Vermont, Virginia, and Washington.
Arkansas and Oregon are SBE-FP — federal platform, so the moratorium applies. The remaining 28 states are FFM.
Each SBE sets its own certification requirements, its own training, and its own deadlines, and several of those deadlines land well before November 1. If a new producer is licensed in one of the 21 states above, that is a live path for 2027. Confirm the requirements with that exchange directly rather than assuming they mirror the FFM.
What CMS says this costs agencies — in CMS’s own numbers
This is the section of the rule that deserves an agency’s attention, and it is the section the trade coverage skips.
CMS ran the economics and published them. Absent the moratorium, the agency estimates 19,982 agents and brokers would have registered during the affected window for PY2027. Of those, about 6,956 would have gone on to write active enrollments during Open Enrollment.
CMS then estimates the lost commission at $71 million to $98 million — roughly $10,000 to $14,000 per affected producer. Notably, CMS does not characterize that money as destroyed. It describes it as a transfer: commission revenue moving from new agents who cannot register to established agents who already hold PY2026 agreements.
On the agency side, CMS is blunt. It estimates that roughly half of those 19,982 producers are agency-affiliated — recruited, hired, trained, and licensed over the summer in the normal run-up to Open Enrollment. Because the moratorium landed in September, the rule states that those investments “are lost.” It further acknowledges the pause “could also lead to job losses” for producers whose income depends on FFM business.
Then CMS does something agencies should not overlook: it explicitly asks for comment on “the magnitude of the potential operational losses for agencies and brokerages and the potential for job losses.”
That is an open invitation. If your agency carried recruiting, licensing, and training costs for producers who are now sidelined, you have standing to document it on the record.
How to comment
Comments are due by November 21, 2026, referencing file code CMS-9872-IFC. Submit electronically at the docket, CMS-2026-3202, on Regulations.gov. Because this was issued as an interim final rule, CMS has said it will weigh comments in deciding whether to retain, modify, or rescind the authority it just created — so the comment period is not a formality.
Specific, documented numbers from real agencies carry more weight here than general objection.
Why CMS did this
The rule is built on enforcement data, and the figures are substantial. From 2023 through 2025, CMS received more than 624,000 consumer complaints involving unauthorized enrollments or unauthorized plan switching that issuers confirmed on review — roughly 300,000 of them in 2025 alone.
CMS’s case for targeting new registrants rests on one statistic in particular: agents and brokers who first registered for PY2026 made up about 11% of registered agents with at least one active enrollment, but accounted for about 30% of the 569 Notices of Intent to Terminate CMS issued in July and August 2026. Those notices went to producers submitting implausible volumes of applications without applicant identifying information such as a Social Security Number.
CMS also flags a structural problem it says existing tools cannot reach: agents terminated in a prior year can form new corporate entities and re-enter as new registrants.
Two things are worth stating plainly. These are CMS’s findings and CMS’s rationale. They do not suggest that new agents as a group act improperly — the overwhelming majority are legitimate producers who now bear the cost of a control aimed at a small number of bad actors.
The PY2027 safeguards coming regardless of the moratorium
The pause is temporary. The system changes behind it are not, and they will reshape day-to-day workflow for every ACA producer — including the ones who register without any trouble. CMS describes four, and notes they are not yet final:
- Renewed identity proofing. All agents and brokers will re-verify identity and connect to CMS systems through Login.gov or ID.me.
- Verifiable SSNs or immigration document numbers on every agent- or broker-assisted application, for all non-newborn applicants.
- System blocks preventing an agent or broker from being added to applications that consumers should be completing themselves on HealthCare.gov.
- Electronic consumer authorization before an agent or broker can take any action on an application or enrollment, required of approved EDE partners.
The fourth is the operational one. Documented, electronic consent before you touch an application changes how you take a lead from first contact to submitted app. If your process still relies on informal verbal consent, rebuild it now — not in January.
Dates to put on the calendar
- September 22, 2026 — Interim final rule effective; moratorium begins.
- September 23, 2026 — Rule published in the Federal Register.
- November 1, 2026 — PY2027 Open Enrollment begins, with the moratorium in force.
- November 21, 2026 — Comment deadline (CMS-9872-IFC, docket CMS-2026-3202).
- February 1, 2027 — Scheduled end of the moratorium, unless CMS lifts, extends, or modifies it.
What to do this week
Split your roster. Sort every producer into one of two buckets: held a PY2026 Exchange agreement, or did not. Everything downstream depends on that line. Do it before you build an OEP schedule around headcount that may not be able to write.
Get your returning agents certified early. The 20% of PY2026 registrants CMS expects not to return is capacity your agency can absorb — but only with producers who are certified and ready on November 1. Our FFM certification walkthrough covers the Login.gov and ID.me account linking step by step.
Redirect your new producers rather than benching them. An agent who cannot write FFM business for this OEP can still write, and the license you paid for still earns. Depending on the state and the agent: full-SBE marketplace business, off-exchange individual plans, Medicare (AEP runs October 15 through December 7 and needs no FFM registration), group health, and ancillary, dental, and vision. A first-year producer with no FFM path in 2027 is not a producer without a 2027.
Fix your consent workflow now. Electronic consumer authorization, verifiable SSNs, and identity proofing are coming for everyone. Agencies that tighten documentation ahead of the deadline will not spend Open Enrollment fighting their own process.
File a comment if this cost you money. CMS asked for it directly. Documented agency losses are the kind of input that shapes whether this authority gets modified.
Where this leaves 2027
For established agents, the near-term math is not unfavorable — CMS’s own analysis describes commission revenue shifting toward producers who already hold agreements. For agencies that invested in growing a new ACA bench this year, the cost is real and CMS has said so in writing.
The longer-term signal is the one to plan around. With § 155.220(o) now on the books, entry to the Federal Marketplace is a gate CMS can close at will, and the PY2027 safeguards point the same direction: consent, identity, and documentation are moving from best practice to the price of admission. Build the compliance habits this year, and the next round of controls is a formality instead of a scramble.
Independent Health Agents will keep tracking CMS guidance affecting the moratorium and PY2027 certification. If you are working out where your new producers fit this Open Enrollment, reach out — we will help you map it.
Source: Patient Protection and Affordable Care Act: Temporary Moratoria on Certain Agent and Broker Registration to Participate in the Exchanges, HHS interim final rule, document 2026-19493 (CMS-9872-IFC).
This article is general information for licensed insurance professionals and is not legal or compliance advice. The interim final rule may be modified by subsequent Federal Register notice; verify current requirements with CMS and with each State-based Exchange before acting.
